Ana Paula Rodríguez

ORCID: 0000-0001-8763-6957
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Control and Dynamics of Mobile Robots
  • Robotic Path Planning Algorithms
  • Antibiotic Use and Resistance
  • Immigration and Intercultural Education
  • Emergency and Acute Care Studies
  • Migration, Racism, and Human Rights
  • Modular Robots and Swarm Intelligence
  • Human Rights and Immigration
  • Pharmaceutical Practices and Patient Outcomes
  • Kawasaki Disease and Coronary Complications
  • Nosocomial Infections in ICU
  • Migration and Labor Dynamics
  • Advanced Malware Detection Techniques
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • COVID-19 Clinical Research Studies
  • Nursing care and research
  • Systemic Lupus Erythematosus Research
  • Patient Safety and Medication Errors
  • Sepsis Diagnosis and Treatment
  • Patient Satisfaction in Healthcare
  • Regional Socio-Economic Development Trends
  • Nursing Diagnosis and Documentation
  • Social and Political Issues
  • Peripheral Neuropathies and Disorders
  • Inflammasome and immune disorders

Instituto de Efectividad Clínica y Sanitaria
2023-2025

Hospital Pedro de Elizalde
2003-2022

Brazilian Naval School
2018

Complejo Hospitalario de Ourense
2016

Universidade Federal do Rio de Janeiro
2014

Introduction: In the pediatric setting, overprescribing of antibiotics contributes to rise multidrug-resistant organisms. Antimicrobial stewardship programs (ASPs) are recommended optimize antibiotic use and combat resistance. However, implementation ASPs in low- middle-income countries faces several challenges. This study aimed evaluate process a multifaceted ASP 2 hospitals Argentina. Methods: A qualitative was conducted two large public children’s Argentina, using semistructured...

10.1097/pq9.0000000000000788 article EN cc-by-nc-nd Pediatric Quality and Safety 2025-01-01

Background: Primary care has been essential in ensuring the continuity of health services for patients with COVID-19 and other conditions. We aimed to increase adoption evidence-based interventions identify clinical deterioration adult confirmed or suspected respiratory at primary level. Methods: implemented specific nine Health Care Centers (PHCC) through a Quality Improvement Collaborative (QIC) an interrupted time-series design. Interventions included triage acute symptoms, NEWS2 scale,...

10.1101/2025.02.12.25321948 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2025-02-13

During the COVID-19 pandemic, emergence of multidrug-resistant (MDR) pathogens, driven by heightened antibiotic usage and device-associated infections, has posed significant challenges to healthcare. This study reports an outbreak Proteus mirabilis producing NDM-5 CTX-M-15 β-lactamases in a hospital Buenos Aires, Argentina, from October 2020 April 2021. To our knowledge, this represents first documented NDM-5-producing P. country. Eighty-two isolates were recovered 40 patients, 41.5% blood...

10.20944/preprints202504.1221.v1 preprint EN 2025-04-15

Aim To study the influence of prednisone dose during first month after systemic lupus erythematosus (SLE) diagnosis (prednisone-1) on glucocorticoid burden subsequent 11 months (prednisone-2–12). Methods 223 patients from Registro Español de Lupus Eritematoso Sistémico inception cohort were studied. The cumulative prednisone-1 and prednisone-2–12 calculated recoded into a four-level categorical variable: no prednisone, low (up to 7.5 mg/day), medium 30 mg/day) high (over mg/day). association...

10.1136/lupus-2016-000153 article EN cc-by-nc Lupus Science & Medicine 2016-08-01

Background There are only a few studies on handoff quality and adverse events (AEs) rigorously evaluating improvement programmes’ effectiveness. None of them have been conducted in low middle-income countries. We aimed to evaluate the effect programme implementation reducing AE frequency paediatric intensive care units (PICUs). Methods Facility-based, cluster-randomised, stepped-wedge trial six Argentine PICUs five hospitals, with >20 admissions per month. The study was from July 2018 May...

10.1136/bmjqs-2020-012370 article EN BMJ Quality & Safety 2021-04-23

Abstract Background We aimed to test the feasibility of a multifaceted intervention enhance quality antibiotic prescription by reducing its overuse and increasing use narrow-spectrum agents, comprising range antimicrobial stewardship strategies in LMIC pediatric hospitals. Methods implemented improvement (QI) initiative for treatment three groups infections: acute lower respiratory infections (ALRI), urinary tract (UTI), skin soft tissue (SSTI) six units two academic used an uncontrolled...

10.1101/2024.02.11.24302598 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-02-13

Abstract Surgical site infections (SSIs) are a major health care issue, with worse outcomes and higher costs in Latin America than other countries. To reduce SSIs colorectal surgery (CRS), we conducted mixed-method study between May December 2021, which included literature review, Delphi expert consensus panel, SSI reduction recommendations. The review identified 150 relevant articles, deriving 19 recommendations based on the GRADE framework. A panel of 14 experts from Argentina, Chile,...

10.1097/ipc.0000000000001373 article EN Infectious Diseases in Clinical Practice 2024-06-05

Background There is limited evidence from antimicrobial stewardship programmes in less-resourced settings. This study aimed to improve the quality of antibacterial prescriptions by mitigating overuse and promoting use narrow-spectrum agents intensive care units (ICUs) a middle-income country. Methods We established improvement collaborative (QIC) model involving nine Argentine ICUs over 11 months with 16-week baseline period (BP) 32-week implementation (IP). Our intervention package included...

10.1136/bmjqs-2024-017069 article EN BMJ Quality & Safety 2024-08-15

Lung cancer is the leading cause of death worldwide, also in Chile, where main risk factor smoking. Early detection using low-dose computed tomography has been shown to reduce mortality from this cause, but there are still no formal screening recommendations Chile.

10.4067/s0034-98872024000500607 article EN Revista médica de Chile 2024-05-01

10.5281/zenodo.7603288 article PT cc-by Zenodo (CERN European Organization for Nuclear Research) 2023-02-05

10.5281/zenodo.7603297 article ES cc-by Zenodo (CERN European Organization for Nuclear Research) 2023-02-05

10.5281/zenodo.7603479 article EN cc-by Zenodo (CERN European Organization for Nuclear Research) 2023-02-05
Coming Soon ...